Drug Information Association Logo
Corporate Tagline

Current Initiatives in the Area of Active Pharmaceutical Ingredients (API)

| Online

« Back to Listing

Overview 

Continuing Education Credits and Certificate Program units are not available for Archived Webinars.


Discuss Ongoing Initiatives Impacting Active Pharmaceutical ingredients (APIs)

Join this interactive webinar to hear expert perspectives on ICH Q11Development and Manufacture of Drug Substances as well as the Mock S2 Project European Federation of Pharmaceutical Industries and
Associations (EFPIA). The scope of this webinar is Chemicals (Small Molecules).


This webinar has been developed by the
Regulatory Affairs SIAC - CMC Working Group


This archived webinar is available through June 13, 2013.

Featured Topics 

Focusing on APIs:

  • Critical Quality Attributes (CQA), Critical Process Parameters, and Control Strategy
  • Science and Risk based approach to Process Development
  • Design Space
  • Post-approvals Change Management Protocols
  • Selection of Starting Materials
  • CTD Section 3.2.S.2

Who Should Attend 

Professionals involved in:

  • Quality Compliance/Quality Assurance
  • API Development and Manufacturing
  • Regulatory Affairs
  • CMC Life Cycle Management
  • CMC Project Management

Learning Objectives 

 At the conclusion of this webinar, participants should be able to:
  • Explain the latest updates in the API arena
  • Describe key points from ICH Q11 and EFPIA Mock S2

Contact Information 

Archived Webinar Information
Carolyn Callahan
DIA North American
Phone +1.215.442.6194
Fax +1-215.442.6199
Carolyn.Callahan@diahome.org

Technical Requirements 

Click here for minimum system requirements.

Presenter(s) 

Previous Next

Agenda  

Day 1 Thursday, June 14, 2012

  • 7:00AM - 11:59PM

    Current Initiatives in the Area of Active Pharmaceutical Ingredients (API)

    Speaker(s):

    • Current initiatives in the Area of Active Pharmaceutical Ingredients (API)
      Yasmin de Faria Krim, PharmD,MSc
      Manager, Global CMC Regulatory Affairs
      Janssen Pharmaceutical Companies of Johnson & Johnson, Belgium
    • Betsy P. Fritschel, MS
      Director, Regulatory Intelligence, Quality & Compliance Worldwide
      Johnson & Johnson, United States
    • Frank Montgomery, PhD
      CMC Director and Group Manager
      EFPIA / Astrazeneca, United Kingdom

Registration Fees 

Other Fees

Government (Full Time) Individual
$125.00
Charitable Nonprofit/Academia Individual
$175.00
Group Site
$799.00
Group Plus
$995.00

Member

Member Individual
$250.00

Non-Member

NonMember Individual
$295.00
Register Online

Unless otherwise disclosed, the statements made by speakers represent their own opinions and not necessarily those of the organization they represent, or that of the Drug Information Association. Speakers, agenda and CE information are subject to change without notice. Recording of any DIA educational material in any type of media is prohibited without prior written consent from DIA.

« Back to Listing Back To Top